User profiles for Natia Dvali

Natia Dvali

Infectious Diseases, AIDS and Clinical Immunology Research Center
Verified email at aidscenter.ge
Cited by 308

[HTML][HTML] Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia

N Chkhartishvili, RR Kempker, N Dvali… - BMC infectious …, 2013 - Springer
Background Improved tests to diagnose latent TB infection (LTBI) are needed. We sought to
evaluate the performance of two commercially available interferon-gamma release assays (…

[HTML][HTML] Etiologic agents of central nervous system infections among febrile hospitalized patients in the country of Georgia

…, T Davitashvili, T Samkharadze, R Chlikadze, N Dvali… - PloS one, 2014 - journals.plos.org
Objectives There is a large spectrum of viral, bacterial, fungal, and prion pathogens that
cause central nervous system (CNS) infections. As such, identification of the etiological agent …

High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment

…, L Gatserelia, N Chkhartishvili, N Dvali… - Hepatology …, 2015 - Wiley Online Library
Aim The first hepatitis C virus (HCV) recombinant, RF2k/1b, was initially described from
Russia and has since then been identified from patients in Ireland, Estonia, Uzbekistan and …

[HTML][HTML] Late presentation of HIV infection in the country of Georgia: 2012-2015

…, M Tsintsadze, L Sharvadze, P Gabunia, N Dvali… - PLoS …, 2017 - journals.plos.org
Late presentation for HIV care has important individual and population implications. The
objective of this study was to explore the problem of late presentation in the country of Georgia. …

[HTML][HTML] Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia

N Chkhartishvili, L Sharvadze, N Dvali… - AIDS Research and …, 2014 - Springer
Background Data on the effectiveness of second-line antiretroviral therapy (ART) in resource-limited
countries of Eastern Europe is limited. Objective of this study was to evaluate …

Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia

N Dvali, MM Parker, N Chkhartishvili… - Journal of medical …, 2012 - Wiley Online Library
In order to describe HIV‐1 subtypes and drug resistance mutations in Georgia, blood samples
from 153 patients infected with HIV‐1 collected from 2006 to 2008 were genotyped. Of …

Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naive, HIV-infected individuals in New York State

…, J Smith, D Lamson, A Aydemir, N Dvali… - AIDS patient care and …, 2007 - liebertpub.com
The duration of HIV infection is usually unknown for most patients entering into HIV care. Data
on the frequency at which resistance mutations are detected in these patients are needed …

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia

E Karkashadze, N Dvali, N Bolokadze… - Journal of Medical …, 2019 - Wiley Online Library
Human immunodeficiency virus (HIV) drug resistance is a major threat to the sustained
impact of antiretroviral therapy (ART). We studied the epidemiology of drug resistance in the …

[HTML][HTML] Outcomes of universal access to antiretroviral therapy (ART) in Georgia

…, N Chkhartishvili, L Sharvadze, N Dvali… - AIDS research and …, 2011 - hindawi.com
Since 2004, Georgia achieved universal access to free antiretroviral therapy (ART). A retrospective
cohort study was conducted to evaluate the outcomes of Georgia's ART program. The …

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

…, L Sharvadze, A Abutidze, N Dvali… - Hepatology …, 2018 - Wiley Online Library
Aim Hepatitis C virus (HCV) recombinant form RF1_2k/1b is common in ethnic Georgians.
This chimera virus contains genomic fragments of genotype 2 and genotype 1 and is …